NASDAQ: INTU

INTUIT INC.

CIK 0000896878 · SIC 7372 · Prepackaged Software

Mega Revenue $18.8B Assets $39.3B as of Aug 16, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.

8-K Filed Aug 25, 2026 · Period ending Aug 25, 2026

Summary not yet generated.

8-K Filed Jun 11, 2026 · Period ending Jun 11, 2026

Intuit raises $1.75B in senior notes to refinance debt, extends maturities to 2031 and 2036

2 material changes detected. Sign up free to read the summary.

Partner

Trade INTU commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

424B5 Filed Jun 10, 2026

Intuit prices $1.75B debt offering: $750M 4.950% 2031 notes and $1B 5.500% 2036 notes

4 material changes detected. Sign up free to read the summary.

424B5 Filed Jun 8, 2026

Intuit prices debt offering of two series of senior unsecured notes; terms not yet disclosed

5 material changes detected. Sign up free to read the summary.

8-K Filed May 20, 2026 · Period ending May 20, 2026

Intuit announces 17% workforce cut, $300-340M restructuring charge alongside Q3 earnings

5 material changes detected. Sign up free to read the summary.

10-Q Filed May 20, 2026 · Period ending Apr 30, 2026

revenue $8.56B, net income $3.06B. Intuit announces restructuring, doubles buybacks, launches AI agents in production

5 material changes detected. Sign up free to read the summary.

8-K Filed Apr 28, 2026 · Period ending Apr 28, 2026

Intuit consolidates business units as Small Business Group GM Marianna Tessel departs

2 material changes detected. Sign up free to read the summary.

8-K Filed Mar 16, 2026 · Period ending Mar 16, 2026

Intuit executives terminate all stock sale plans as company accelerates up to $3.5B buyback

3 material changes detected. Sign up free to read the summary.

10-Q Filed Feb 26, 2026 · Period ending Jan 31, 2026

Summary not yet generated.

10-K Filed Sep 3, 2025 · Period ending Jul 31, 2025

Summary not yet generated.

10-Q Filed May 22, 2025 · Period ending Apr 30, 2025

Summary not yet generated.

10-K Filed Sep 4, 2024 · Period ending Jul 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed May 20, 2026 (period ending Apr 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations (Unaudited)

(In millions, except per share amounts)

Description Three months ended April 30, 2026 Three months ended April 30, 2025 Nine months ended April 30, 2026 Nine months ended April 30, 2025
Net revenue:
Service 7,759 6,971 15,128 13,109
Product and other 799 783 1,966 1,891
Total net revenue 8,558 7,754 17,094 15,000
Costs and expenses:
Cost of revenue:
Cost of service revenue 1,317 1,138 3,122 2,790
Cost of product and other revenue 14 18 47 52
Amortization of acquired technology 43 38 131 112
Selling and marketing 1,793 1,618 4,270 3,784
Research and development 840 707 2,519 2,127
General and administrative 409 394 1,232 1,177
Amortization of other acquired intangible assets 122 120 364 360
Restructuring 1 14
Total costs and expenses 4,538 4,034 11,685 10,416
Operating income 4,020 3,720 5,409 4,584
Interest expense (70) (68) (186) (188)
Interest and other income, net 97 32 254 72
Income before income taxes 4,047 3,684 5,477 4,468
Income tax provision 983 864 1,274 980
Net income 3,064 2,820 4,203 3,488
Basic net income per share 11.10 10.09 15.13 12.45
Shares used in basic per share calculations 276 280 278 280
Diluted net income per share 11.09 10.02 15.05 12.33
Shares used in diluted per share calculations 276 282 279 283

Condensed Consolidated Balance Sheets (Unaudited)

(In millions)

Description April 30, 2026 July 31, 2025
ASSETS
Current assets:
Cash and cash equivalents 4,681 2,884
Investments 2,099 1,668
Accounts receivable, net 834 530
Notes receivable held for investment 1,662 1,403
Notes receivable held for sale 69
Income taxes receivable 52 50
Prepaid expenses and other current assets 680 496
Current assets before funds receivable and amounts held for customers 10,077 7,031
Funds receivable and amounts held for customers 7,760 7,076
Total current assets 17,837 14,107
Long-term investments 176 94
Property and equipment, net 996 961
Operating lease right-of-use assets 601 541
Goodwill 13,982 13,980
Acquired intangible assets, net 4,807 5,302
Long-term deferred income tax assets 113 1,222
Other assets 818 751
Total assets 39,330 36,958
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Short-term debt 750
Accounts payable 1,096 792
Accrued compensation and related liabilities 766 858
Deferred revenue 1,055 1,019
Other current liabilities 849 625
Current liabilities before funds payable and amounts due to customers 4,516 3,294
Funds payable and amounts due to customers 7,760 7,076
Total current liabilities 12,276 10,370
Long-term debt 5,412 5,973
Operating lease liabilities 655 597
Other long-term obligations 358 308
Total liabilities 18,701 17,248
Commitments and contingencies
Stockholders’ equity:
Preferred stock
Common stock and additional paid-in capital 22,745 21,635
Treasury stock, at cost (24,916) (21,543)
Accumulated other comprehensive loss (54) (50)
Retained earnings 22,854 19,668
Total stockholders’ equity 20,629 19,710
Total liabilities and stockholders’ equity 39,330 36,958

Condensed Consolidated Statements of Cash Flows (Unaudited)

(In millions)

Description Nine months ended April 30, 2026 Nine months ended April 30, 2025
Cash flows from operating activities:
Net income 4,203 3,488
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation 133 129
Amortization of acquired intangible assets 495 472
Non-cash operating lease cost 77 56
Share-based compensation expense 1,549 1,478
Deferred income taxes 1,150 (278)
Provision for credit losses 189 101
Other (150) 13
Total adjustments 3,443 1,971
Changes in operating assets and liabilities:
Accounts receivable (303) (267)
Income taxes receivable (2) 69
Prepaid expenses and other assets (148) (227)
Accounts payable 281 285
Accrued compensation and related liabilities (102) (173)
Deferred revenue 33 84
Operating lease liabilities (65) (59)
Other liabilities 167 655
Total changes in operating assets and liabilities (139) 367
Net cash provided by operating activities 7,507 5,826
Cash flows from investing activities:
Purchases of corporate and customer fund investments (2,204) (1,080)
Sales of corporate and customer fund investments 133 168
Maturities of corporate and customer fund investments 1,655 656
Purchases of property and equipment (148) (99)
Originations and purchases of notes receivable held for investment (4,930) (2,873)
Sales of notes receivable originally classified as held for investment 1,389 300
Principal repayments of notes receivable held for investment 3,125 1,952
Other (120) (117)
Net cash used in investing activities (1,100) (1,093)
Cash flows from financing activities:
Proceeds from borrowings under secured revolving credit facilities 186 364
Proceeds from issuance of stock under employee stock plans 136 263
Payments for employee taxes withheld upon vesting of restricted stock units (575) (612)
Cash paid for purchases of treasury stock (3,341) (2,026)
Dividends and dividend rights paid (1,015) (888)
Net change in funds receivable and funds payable and amounts due to customers 633 1,251
Other (7) (4)
Net cash used in financing activities (3,983) (1,652)
Effect of exchange rates on cash, cash equivalents, restricted cash, and restricted cash equivalents 9 4
Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents 2,433 3,085
Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period 9,481 7,099
Cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period 11,914 10,184
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents reported within the condensed consolidated balance sheets to the total amounts reported on the condensed consolidated statements of cash flows
Cash and cash equivalents 4,681 5,443
Restricted cash and restricted cash equivalents included in funds receivable and amounts held for customers 7,233 4,741
Total cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period 11,914 10,184
Supplemental schedule of non-cash investing activities:
Transfers of notes receivable originated or purchased as held for investment to held for sale 1,427 333

Amounts as printed on the EDGAR/iXBRL face — (In millions, except per share amounts); (In millions). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing